相关实验视频

Updated: Jun 26, 2025

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

敏感的双特异性化学T细胞受体用于癌症治疗

Sylvain Simon¹, Grace Bugos^1,2, Rachel Prins¹

¹Translational Sciences and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.

Research square

|May 15, 2024

概括

新型嵌合式T细胞受体 (ChTCRs) 为治疗血液癌症提供了更好的抗原敏感性和多特异性. 这些ChTCRs克服了瘤抗原逃逸,增强了血液恶性瘤的持久疗效.

科学领域:

免疫学免疫学免疫学
在瘤学瘤学.
生物技术是生物技术.

背景情况:

化学抗原受体 (CAR) T细胞疗法对血液性恶性瘤有希望,但受到瘤抗原逃逸的限制.
目前的CARs需要高的抗原水平,并且不能完全复制T细胞受体 (TCR) 功能,因此需要改进的T细胞参与受体.

结论:

ChTCRs代表了一个广泛适用于工程T细胞的平台,以克服血液恶性瘤中的抗原异质性.
这种方法解决了当前CAR T细胞疗法中复发的关键机制,为改善患者治疗结果提供了一条道路.

更多相关视频

Tracking Bispecific Antibody-Induced T Cell Trafficking Using Luciferase-Transduced Human T Cells

Tracking Bispecific Antibody-Induced T Cell Trafficking Using Luciferase-Transduced Human T Cells

Published on: May 12, 2023

In Vitro Tumor Cell Rechallenge For Predictive Evaluation of Chimeric Antigen Receptor T Cell Antitumor Function

In Vitro Tumor Cell Rechallenge For Predictive Evaluation of Chimeric Antigen Receptor T Cell Antitumor Function

Published on: February 27, 2019

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.